Unlike CB1 but like CB2 receptors, activation of these molecular targets has been associated with amelioration of glucose intolerance, perturbed intestinal permeability, insulin resistance, and/or obesity (7, –, 9). The gene discussed is CNR1; the disease is Glucose intolerance.